These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 128152)

  • 21. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
    Huijgens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
    Thromb Res; 1981 Nov; 24(3):267-70. PubMed ID: 7336383
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
    Ali M; McDonald JW
    J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet survival.
    Mustard JF
    Thromb Haemost; 1978 Aug; 40(1):154-62. PubMed ID: 725846
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
    Adams JH; Mitchell JR
    Thromb Haemost; 1979 Aug; 42(2):603-10. PubMed ID: 505367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sulphinpyrazone and dipyridamole on capillary bleeding time in man.
    Weston MJ; Rubin MH; Langley PG; Westaby S; Williams R
    Thromb Res; 1977 Jun; 10(6):833-40. PubMed ID: 882967
    [No Abstract]   [Full Text] [Related]  

  • 28. A controlled study of the effect of sulfinpyrazone on platelet survival and on platelet-bound 14C-serotonin release in patients with previous myocardial infarction.
    Cortellaro M; Boschetti C; Fassio G; Basagni M; Polli EE
    Acta Haematol; 1979; 61(2):68-74. PubMed ID: 217218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of action of sulphinpyrazone.
    Wallis RB
    Thromb Res Suppl; 1983; 4():31-8. PubMed ID: 6415857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulphinpyrazone prevents in vivo the inhibitory effect of aspirin on rat platelet cyclo-oxygenase activity.
    Rajtar G; Cerletti C; Livio M; de Gaetano G
    Biochem Pharmacol; 1981 Oct; 30(20):2773-6. PubMed ID: 6797431
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in man.
    Maguire ED; Pay GF; Turney J; Wallis RB; Weston MJ; White AM; Williams LC; Woods HF
    Haemostasis; 1981; 10(3):153-64. PubMed ID: 7262644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of warfarin action by sulphinpyrazone.
    Bailey RR; Reddy J
    Lancet; 1980 Feb; 1(8162):254. PubMed ID: 6101699
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits.
    Mustard JF; Rowsell HC; Smythe HA; Senyi A; Murphy EA
    Blood; 1967 Jun; 29(6):859-66. PubMed ID: 6029001
    [No Abstract]   [Full Text] [Related]  

  • 34. An in vitro method for platelet morphological studies employing a reconstituted collagen substrate.
    Albert EN; Daniel RE; Whiting JD; Bailey JM
    Scan Electron Microsc; 1979; (3):131-8. PubMed ID: 392702
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet survival time in severe chronic airway obstruction.
    Steele P; Ellis JH; Genton E
    Chest; 1975 Feb; 67(2 Suppl):46S-47S. PubMed ID: 1112110
    [No Abstract]   [Full Text] [Related]  

  • 36. Kinetics and in vivo redistribution of (111)Indium-labelled human platelets after intravenous protamine sulphate.
    Heyns AD; Lötter MG; Badenhorst PN; Kotze H; Killian FC; Herbst C; van Reenen OR; Minnaar PC
    Thromb Haemost; 1980 Oct; 44(2):65-8. PubMed ID: 7455993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulphinpyrazone, aspirin, and uric acid.
    Newland HR
    Lancet; 1980 Apr; 1(8171):770. PubMed ID: 6103187
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of the effect of sulphinpyrazone ('Anturan') on blood viscosity.
    Johnston RV; Lowe GD; Drummond MM; Forbes CD; Prentice CR
    Curr Med Res Opin; 1979; 6(4):271-3. PubMed ID: 527353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of cancer cell stickiness, a model for the testing of in vivo thrombocyte aggregation inhibitors. IV. Effect of sulfinpyrazone].
    Gastpar H
    Fortschr Med; 1978 Sep; 96(36):1823-7. PubMed ID: 700559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: Modification of the hyperacute reaction in the rat by sulphinpyrazone.
    Jamieson SW
    Thromb Diath Haemorrh; 1975 Sep; 34(1):348-9. PubMed ID: 1103359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.